A conformational checkpoint between DNA binding and cleavage by CRISPR-Cas9

The Cas9 endonuclease is widely utilized for genome engineering applications by programming its single-guide RNA and ongoing work is aimed at improving the accuracy and efficiency of DNA targeting. DNA cleavage of Cas9 is controlled by the conformational state of the HNH nuclease domain, but the mechanism that governs HNH activation at on-target DNA while reducing cleavage activity at off-target sites remains poorly understood. Using single-molecule FRET, we identified an intermediate state of S. pyogenes Cas9, representing a conformational checkpoint between DNA binding and cleavage. Upon DNA binding, the HNH domain transitions between multiple conformations before docking into its active state. HNH docking requires divalent cations, but not strand scission, and this docked conformation persists following DNA cleavage. Sequence mismatches between the DNA target and guide RNA prevent transitions from the checkpoint intermediate to the active conformation, providing selective avoidance of DNA cleavage at stably bound off-target sites.

[1]  Martin J. Aryee,et al.  GUIDE-Seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases , 2014, Nature Biotechnology.

[2]  Jennifer A. Doudna,et al.  Structures of Cas9 Endonucleases Reveal RNA-Mediated Conformational Activation , 2014, Science.

[3]  Jin-Soo Kim,et al.  Structural roles of guide RNAs in the nuclease activity of Cas9 endonuclease , 2016, Nature Communications.

[4]  Tautvydas Karvelis,et al.  Direct observation of R-loop formation by single RNA-guided Cas9 and Cascade effector complexes , 2014, Proceedings of the National Academy of Sciences.

[5]  J. Keith Joung,et al.  731. High-Fidelity CRISPR-Cas9 Nucleases with No Detectable Genome-Wide Off-Target Effects , 2016 .

[6]  J. Doudna,et al.  A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.

[7]  Jennifer A. Doudna,et al.  Conformational control of DNA target cleavage by CRISPR–Cas9 , 2015, Nature.

[8]  David A. Scott,et al.  Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells , 2014, Nature Biotechnology.

[9]  J. Andrew McCammon,et al.  Striking Plasticity of CRISPR-Cas9 and Key Role of Non-target DNA, as Revealed by Molecular Simulations , 2016, ACS central science.

[10]  Jennifer A. Doudna,et al.  Structures of a CRISPR-Cas9 R-loop complex primed for DNA cleavage , 2016, Science.

[11]  David A. Scott,et al.  Rationally engineered Cas9 nucleases with improved specificity , 2015, Science.

[12]  M. Jinek,et al.  Structural Plasticity of PAM Recognition by Engineered Variants of the RNA-Guided Endonuclease Cas9. , 2016, Molecular cell.

[13]  M. Jinek,et al.  Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease , 2014, Nature.

[14]  Rodolphe Barrangou,et al.  CRISPR-Cas systems: Prokaryotes upgrade to adaptive immunity. , 2014, Molecular cell.

[15]  Jacob E Corn,et al.  Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA , 2016, Nature Biotechnology.

[16]  J. Oost,et al.  Unravelling the structural and mechanistic basis of CRISPR–Cas systems , 2014, Nature Reviews Microbiology.

[17]  E. Lander,et al.  Development and Applications of CRISPR-Cas9 for Genome Engineering , 2014, Cell.

[18]  Jennifer A. Doudna,et al.  Biology and Applications of CRISPR Systems: Harnessing Nature’s Toolbox for Genome Engineering , 2016, Cell.

[19]  Jennifer A. Doudna,et al.  A Cas9–guide RNA complex preorganized for target DNA recognition , 2015, Science.

[20]  Morgan L. Maeder,et al.  Delivery and Specificity of CRISPR-Cas9 Genome Editing Technologies for Human Gene Therapy. , 2015, Human gene therapy.

[21]  J. Doudna,et al.  Expanding the Biologist's Toolkit with CRISPR-Cas9. , 2015, Molecular cell.

[22]  Phillip A. Sharp,et al.  Target specificity of the CRISPR-Cas9 system , 2014, Quantitative Biology.

[23]  J. Doudna,et al.  The new frontier of genome engineering with CRISPR-Cas9 , 2014, Science.

[24]  Samuel H Sternberg,et al.  Real-time observation of DNA recognition and rejection by the RNA-guided endonuclease Cas9 , 2016, Nature Communications.

[25]  Kira S. Makarova,et al.  Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems , 2016, Science.

[26]  Michelle J. Wu,et al.  High-throughput biochemical profiling reveals Cas9 off-target binding and unbinding heterogeneity , 2016, bioRxiv.

[27]  Jennifer A. Doudna,et al.  DNA interrogation by the CRISPR RNA-guided endonuclease Cas9 , 2014, Nature.

[28]  Osamu Nureki,et al.  Structural Basis for the Altered PAM Specificities of Engineered CRISPR-Cas9. , 2016, Molecular cell.

[29]  R. Barrangou,et al.  Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria , 2012, Proceedings of the National Academy of Sciences.